Fenesa

Fenesa is a medication containing Sorafenib Tosylate, used for targeted therapy in certain cancers. It works by inhibiting tumor growth and may be prescribed for advanced renal cell carcinoma or hepatocellular carcinoma.

Fenesa is primarily used in the treatment of advanced renal cell carcinoma and hepatocellular carcinoma. Sorafenib Tosylate, the active ingredient, is a multi-kinase inhibitor that targets specific proteins involved in tumor growth and angiogenesis. This medication is often considered when other treatments have not been effective. Patients should consult their healthcare provider to understand the specific uses of Fenesa in their treatment plan.

Common effects of Fenesa may include fatigue, hand-foot skin reaction, diarrhea, and hypertension. Some patients may also experience nausea, vomiting, or changes in hair color. These effects can vary in severity and duration, and it is important to discuss any persistent or concerning symptoms with a healthcare professional.

Fenesa should be handled with care, as it is intended for oral use only. Patients should follow their healthcare provider's instructions regarding dosage and administration. It is important to inform your healthcare provider about any other medications you are taking to avoid potential interactions. Additionally, regular monitoring may be required to manage side effects effectively.

Fenesa may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. This can affect the effectiveness of Fenesa or other drugs. Patients should also avoid grapefruit and grapefruit juice, as they can interfere with the metabolism of Sorafenib Tosylate. Always consult a healthcare provider before starting or stopping any medication.